Alternatives to Financing

L. M. Aledort

doi:10.1111/j.1600-0609.1984.tb02600.x

Alternatives to Financing

L. M. Aledort

Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

Abstract

Comprehensive care for hemophilia patients has clearly demonstrated that it is cost effective and offers the patient a better, more active life. However, the cost of underwriting the core personnel has not been adequately addressed or resolved. Alternatives are presented which include a) federal or state support, b) third party reimbursement mechanisms, c) liaisons with blood programs and, d) cost overrides on product.

Original language	English
Pages (from-to)	455-457
Number of pages	3
Journal	Scandinavian Journal of Haematology
Volume	33
Issue number	40 S
DOIs	https://doi.org/10.1111/j.1600-0609.1984.tb02600.x
State	Published - Dec 1984

Keywords

Blood program
Cost override
Federal support

Access to Document

10.1111/j.1600-0609.1984.tb02600.x

Cite this

@article{ada623f6ab1243e88f854acc3b8c3b8d,

title = "Alternatives to Financing",

abstract = "Comprehensive care for hemophilia patients has clearly demonstrated that it is cost effective and offers the patient a better, more active life. However, the cost of underwriting the core personnel has not been adequately addressed or resolved. Alternatives are presented which include a) federal or state support, b) third party reimbursement mechanisms, c) liaisons with blood programs and, d) cost overrides on product.",

keywords = "Blood program, Cost override, Federal support",

author = "Aledort, {L. M.}",

year = "1984",

month = dec,

doi = "10.1111/j.1600-0609.1984.tb02600.x",

language = "English",

volume = "33",

pages = "455--457",

journal = "Scandinavian Journal of Haematology",

issn = "0036-553X",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "40 S",

}

TY - JOUR

T1 - Alternatives to Financing

AU - Aledort, L. M.

PY - 1984/12

Y1 - 1984/12

N2 - Comprehensive care for hemophilia patients has clearly demonstrated that it is cost effective and offers the patient a better, more active life. However, the cost of underwriting the core personnel has not been adequately addressed or resolved. Alternatives are presented which include a) federal or state support, b) third party reimbursement mechanisms, c) liaisons with blood programs and, d) cost overrides on product.

AB - Comprehensive care for hemophilia patients has clearly demonstrated that it is cost effective and offers the patient a better, more active life. However, the cost of underwriting the core personnel has not been adequately addressed or resolved. Alternatives are presented which include a) federal or state support, b) third party reimbursement mechanisms, c) liaisons with blood programs and, d) cost overrides on product.

KW - Blood program

KW - Cost override

KW - Federal support

UR - http://www.scopus.com/inward/record.url?scp=0021139918&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.1984.tb02600.x

DO - 10.1111/j.1600-0609.1984.tb02600.x

M3 - Article

C2 - 6591402

AN - SCOPUS:0021139918

SN - 0036-553X

VL - 33

SP - 455

EP - 457

JO - Scandinavian Journal of Haematology

JF - Scandinavian Journal of Haematology

IS - 40 S

ER -

Alternatives to Financing

Abstract

Keywords

Access to Document

Fingerprint

Cite this